Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 6
Issue 2
Online publication date 2011-04-04
Title Correlation between body fat mass and nonalcoholic fatty liver disease
Author Kuat Oshakbayev, Alexander Nersesov, Eldos Izatullayev, Jamilya Kaybullayeva, Markhaba Nugmanova, Bibigul Ilyassova

The study analyses the impact of a body fat mass onto body composition, as muscle mass, water mass, and bone mass of a body, and also onto such physical parameters, as the basal metabolic ratio (BMR), metabolic age, a bioimpedance in patients with nonalcoholic fatty liver disease (NAFLD). The research included 58 people, of them 32 patients with NAFLD. There were studied anthropometrical indicators, as age, weight, body mass index, also parameters of body composition

In patients group in compare with control group there were significantly raised a visceral fat rating on 3.1 units (р<0.0001), a metabolic age on 9.6 years (р<0.0001), a basal metabolic rate on 209 kkcal/day (р=0.004), a bioimpedance on 25.7 Ohm (р=0.04). In control group in compare with patients group there were significantly raised the percentage of total body water on 9.9% (р<0.0001), the percentage of muscle mass on 13.1% (р<0.0001), and the percentage of bone mass on 0.7% (р<0.0001). BMR starts to be slowed down when fat mass accumulation in organism is between 30 and 40%, and after 40% the BMR starts to go down. Bioimpedance values increases with rises of fat mass in percentage.

Baran, D., Apostol, I. 2007. “Signification of biorhythms for human performance assessment,” Rev. Med. Chir. Soc. Med. Nat. Iasi., in Romanian, Vol.111(1), pp.295-302

Benetos, A., et al., 2008. “All-cause and cardiovascular mortality using the different definitions of metabolic syndrome,” Am. J. Cardiol., Vol.102(2), pp.188-91

Bruch, H., 1958. “Psychological aspects of obesity,” Rev. nutrit. Res., Vol.19, pp.57-62

Brunet-Rossinni, A., Austad, S., 2004. “Ageing studies on bats: a review.,” Biogerontology, Vol.5, 4, pp.211-22

Cani, P., Amar, J., Iglesias, M. et al., 2007. “Metabolic Endotoxemia Initiates Obesity and Insulin Resistance,” Diabetes, Vol.56, 7, pp.1161-772

Clark, J., Brancati, F., Diehl, A., 2003. “The prevalence and etiology of elevated aminotransferase levels in the United States,” Am. J. Gastroenterol., Vol.98, pp.960-67

Cortez-Pinto, H., Camilo, M., Baptista, A., De Oliveira A., De Moura M., 1999. “Non-alcoholic fatty liver: Another feature of the metabolic syndrome?”, Clin. Nutr., Vol.18, 6, pp.353-58

Cotrim, H., Parana, R., Braga, E., Lyra, L., 2000. “Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?,” Am. J. Gastroenterol., Vol.95, pp.3018-3019

de Magalhaes, J., Costa, J., Church, G., 2007. “An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts,” The Journals of Gerontology, Series a, Biological Sciences and Medical Sciences, Vol.62, 2, pp.149-60

Dixon, J., Bhathal, P., O’Brien, P., 2001. “Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese,” Gastroenterology, Vol.121, pp.91-100

Ekstedt, M., Franzen, L., Mathiesen, U. et al., 2006. “Long-term follow-up of patients with nonalcoholic fatty liver disease and elevated liver enzymes,” Hepatology, Vol.44, pp.865-73

Farrell, G., Larter, C., 2006. ”Nonalcoholic fatty liver disease: from steatosis to cirrhosis,” Hepatology, Vol.43, pp.99-112

Friedman, J., 2002. “Fat in all the wrong places,” Nature; 415, pp.268-69

Garg, A., Misra, A., 2002. “Hepatic steatosis, insulin resistance, and adipose tissue disorders,” The Journal of Clinical Endocrinology & Metabolism, Vol.87, 7, pp.3019-3022

Greco, A.V., Mingrone, G., Giancaterini, A. et al., 2002. “Insulin resistance in morbid obesity: Reversal with intramyocellular fat depletion,” Diabetes, Vol.51, 1,

Hamaguchi, M., Kojima, T., Itoh, Y. et al., 2008. “The seferity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation,” The American Journal of Gastroenterology, Vol.102, pp.2417-425

Kurth, T., et al., 2005. “Adiposity is the important risk factor of all kinds of an insult and an ischemic insult” (Brigham and Women's Hospital, Boston, Massachusets), Circulation, Vol.111, pp.1992-1998

Lapach, S., Chubenko, A., Babich, P., 2000. Statistical methods in medical and biologic researches with use Excel [Statisticheskie metodi v mediko-biologicheskih issledovaniyah s ispol1zovaniem Excel], in Russian, Kiev, p.319

Ludwig, J., Viggiano, T., McGill, D. et al., 1980. “Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease,” Mayo Clin Proc., Vol.55, pp.434-38

Marceau, P., Biron, S., Hould, F.S., et al., 1999. “Liver pathology and the metabolic syndrome X in severe obesity,” J. Clin. Endocrinol. Metab., Vol.84, pp.1513-517

Melville, N., 2009. “Changes in Lean Mass Affect Bone-Mineral Density More Than Fat Mass Changes,” American Society for Bone and Mineral Research (ASBMR), 31st Annual Meeting: Abstract 1091, Presented September 12

Misra, A., Khurana, L., 2008. “Obesity and the Metabolic Syndrome in Developing Countries,” J. Clin. Endocrinol. Metab., 93, (Suppl.1), pp.9-30

Oshakbayev, K., 2010. “Metabolic syndrome: an etiology, pathogenesis, diagnostics, clinical management, prognosis” [Metabolicheskiy sindrom: etiologia, patogenez, diagnostika, klinicheskiy menedjment i prognoz], Doctoral dissertation in medical sciences, Almaty

Pearl, R., 1928. The rate of living, being an account of some experimental studies on the biology of life duration,”New York: Alfred A. Knopf

Schwartz, M., Woods, S., Seeley, R., 2003. “Is the energy homeostasis system inherently biased toward weight gain?,” Diabetes, Vol.52, 2,

Shirai, K., 2004. “Obesity as the core of the metabolic syndrome and the management of coronary heart disease,” Curr. Med. Res. Opin., Vol.20, 3,

Smith, D., Dollman, J., Withers, R. et al., 1997. “Relationship between maximum aerobic power and resting metabolic rate in young adult women,” Journal of Applied Physiology, Retrieved 2007-11-23

Sothern, R., Cornélissen, G., Yamamoto, T. et al., 2009. “Time microscopy of circadian expression of cardiac clock gene mRNA transcription: Chronodiagnostic and chrono-therapeutic implications,” Clin. Ter., Vol.160, 2, pp.25-34

Starley, B., Calcagno, C., Harrison, S., 2010. “Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection,” Hepatology, Vol.51, 5, pp.1820-832

Wong, V., Hui, A., Tsang, S. et al., 2006. “Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease,” Clin. Gastroenterol. Hepatology, Vol.4, pp.1154-161

Woods, S., Strubbe, J., 1994. “The psychobiology of meals,” Psychon. Bull. Rev., Vol.1, pp.141-55

Keywords Fatty liver disease, body composition, randomized clinical trial
Pages 60-67
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Search in articles
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2562018
Journal Downloads
MHSJ 17477
Total users online -